Salary
💰 $185,500 - $344,500 per year
About the role
- Support the creation and update of a holistic TA strategy for RLT and provide early-phase commercial insights to project teams
- Guide TA-specific internal pipeline development and external licensing / acquisitions opportunities
- Support integrated enterprise alignment across Biomedical Research, Development, Strategy & Growth, and the US and International Commercial units
- Bring external benchmarking, analysis and insights to support the Neuroscience TA Strategy Head in developing TA strategy
- Provide key commercial insights to the R&D project teams, particularly for early phase programs
- Analyse reports and publications to extract key messages, including building product forecasts
- Support development and delivery of TA-specific strategic external insights and commission targeted primary research
- Manage the commercial transition from S&G to the US and International commercial units
- Seek input into TA strategy from other internal experts and complete ad-hoc requests
- Deliver agreed health improvement partnership projects on time and within budget
Requirements
- Advanced degree (PhD, MD or other advanced University degree) or equivalent experience in life science/healthcare; MBA or consulting or equivalent experience highly desirable
- In-depth knowledge of Neuroscience, including multiple tumor types (or track record to acquire required TA expertise effectively and rapidly)
- Experience with NS or demonstrated ability to learn complex, highly technical areas quickly
- Highly agile having the capacity to support multiple strategic Disease Areas within a TA and multiple programs internal and external
- Substantial experience evaluating new product opportunities (through M&A, BD&L and internal research programs)
- At least 5-7 years of Industry pharma and/or medical devices experience in Research & Development and/or Commercial functions with experience conducting, commissioning, analyzing primary research and developing forecasts
- Experience of strategy development and asset shaping early in lifecycle (any functional perspective)
- Recent (post 2015) local US in-market experience; local US experience includes working within the US market with the local US customers, US health care systems / systems